Contact · editorial inquiries
Get in Touch
Questions, corrections, or source suggestions about our BPC-157 TB-500 coverage are welcome. We do not sell anything and cannot offer medical advice.
What we can help with
This contact page is for editorial matters concerning our BPC-157 TB-500 coverage. If you have spotted an error, have a peer-reviewed source we should consider, or want to ask about how we summarized a particular study, we would genuinely like to hear from you. Corrections are taken seriously; a digest is only as good as its sources, and we would rather fix a misread quickly than let it stand.
Please note what we cannot do. We are not a clinic, a pharmacy, or a prescriber, and we cannot answer questions about personal use, dosing, or where to obtain any substance. Messages of that kind cannot be answered, and the appropriate place for them is a qualified, licensed healthcare professional.
Send a note
Use the form below to reach the editorial team. A short, specific message — the page, the claim, and the source you have in mind — helps us respond well. We read everything sent through the form, and we prioritize correction and sourcing requests.
For anything touching the regulatory picture, it helps to know that we treat the FDA's own pages as the only source for access and compounding facts, and we keep the regulatory page current to those. If you believe a regulatory statement here is out of date, point us to the FDA page that supersedes it and we will review it.